Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine

Clozapine, a dibenzodiazepine developed in 1961, is a multireceptorial atypical antipsychotic approved for the treatment of resistant schizophrenia. Since its introduction, it has remained the drug of choice in treatment-resistant schizophrenia, despite a wide range of adverse effects, as it is a ve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Drug Saf
Main Authors: De Berardis, Domenico, Rapini, Gabriella, Olivieri, Luigi, Di Nicola, Domenico, Tomasetti, Carmine, Valchera, Alessandro, Fornaro, Michele, Di Fabio, Fabio, Perna, Giampaolo, Di Nicola, Marco, Serafini, Gianluca, Carano, Alessandro, Pompili, Maurizio, Vellante, Federica, Orsolini, Laura, Martinotti, Giovanni, Di Giannantonio, Massimo
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2018
Assuntos:
Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5956953/
https://ncbi.nlm.nih.gov/pubmed/29796248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2042098618756261
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados